Shares of Oruka Therapeutics, Inc. (ORKA) have gained 42.7% over the past four weeks to close the last trading session at $27.44, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$44.89 indicates a potential upside of 63.6%.The average comprises nine short-term price targets ranging from a low of $26.00 to a high of$60.00, with a standard deviation of $9.82. While the lowest est ...